This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
The FDA is also investigating reported side effects of aspiration.
Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.
